Key result
Enzymatically modified LDL triggers the classical complement pathway via C1q recognition of unesterified fatty acids.
Answers are grounded in this paper and cite their sources.
Several studies suggest that the complement system is involved in atherogenesis. To further investigate this question, we have studied the ability of native and modified forms of LDL to bind and activate C1, the complex protease that triggers the classical pathway of complement. Unlike native LDL, oxidized (oxLDL) and enzymatically modified (E-LDL) derivatives were both recognized by the C1q subunit of C1, but only E-LDL particles, obtained by sequential treatment with a protease and then with cholesterol esterase, had the ability to trigger C1 activation. Further investigations revealed that C1q recognizes a lipid component of E-LDL. Several approaches, including reconstitution of model lipid vesicles, cosedimentation, and electron microscopy analyses, provided evidence that C1 binding to E-LDL particles is mediated by the C1q globular domain, which senses unesterified fatty acids generated by cholesterol esterase. The potential implications of these findings in atherogenesis are discussed.
No takes yet. Share an insight, caveat, or question.
Arlaud et al. (2011) studied Atherogenesis. Enzymatically modified LDL (E-LDL) vs. Native LDL and oxidized LDL was evaluated on Ability to bind and activate C1. Enzymatically modified LDL, but not native LDL, activates the classical complement pathway via C1q globular domain recognition of unesterified fatty acids.
Synapse has enriched 10 related papers. Consider them for comparative context: